DIGAMI 2 - Azienda USL di Reggio Emilia
DIGAMI 2 - Azienda USL di Reggio Emilia
DIGAMI 2 - Azienda USL di Reggio Emilia
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
GP IIb/IIIa Inhibitors Reduc e Mo rtality in Diabe tic<br />
Patients with non-ST Segment Elevation Acute<br />
Co ro nary S yndro mes<br />
30-Day Mortality Diabetic Patients PCI<br />
Trial N Odds Ratio & 95% CI Placebo IIb/IIIa<br />
PURSUIT<br />
457<br />
p=0.57<br />
3.3%<br />
2.4%<br />
PRISM<br />
PRISM-PLUS<br />
GUSTO IV<br />
PARAGON A<br />
PARAGON B<br />
Pooled<br />
147<br />
107<br />
239<br />
45<br />
284<br />
1279<br />
p=0.50<br />
p=1.00<br />
p=0.037<br />
p=0.31<br />
p=0.06<br />
p=0.002<br />
2.5%<br />
1.8%<br />
6.5%<br />
7.1%<br />
4.3%<br />
4.0%<br />
0.0%<br />
0.0%<br />
1.2%<br />
0.0%<br />
0.7%<br />
1.2%<br />
0 0.5 1 1.5 2<br />
Breslow-Day: p=0.46 IIb/IIIa Better Placebo Better<br />
Roffi. Circulation 2001;104:2767
Change language